MimoPools™ takes standard peptide library screening studies further with critical applications in antigen-specific T-cell response studies, epitope mapping, and immune monitoring.
Pivotal in the continuing worldwide SARS-CoV-2 research, strategically synthesised peptide pools can contain specific sequences for mutations in key proteins or complete protein sequences for each variant.
Designed For Success
MimoPools™ are expertly designed on a case-by-case basis to include pre-synthesised catalogue peptides or made-to-order sequences, with all of the modification and customisation option typical of a standard peptide library.
The design of truncated peptide pool has been optimised for T-cell studies by the inclusion of four strategically truncated lengths of the same sequence in each pool.
MimoPools™ are available as-synthesised or purified up to 95%. These peptide pools are supplied as freeze-dried aliquots, offering long-term stability, and allowing MimoPools™ to be used and reused at your convenience.